These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 967910)

  • 1. [Tablets. XVII. Effect of pressure on the liberation in vitro of sodium salicylate from prolonged-action tablets].
    Terrier JL; Cruaud-Mangenot O; Duchène D; Puisieux F
    Pharm Acta Helv; 1976; 51(5):144-52. PubMed ID: 967910
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tablets. XV. Influence of Precirol on the in vitro liberation of sodium salicylate. The process of coating the grains].
    Terrier JL; Paris J; Duchène D; Puisieux F
    Pharm Acta Helv; 1975; 50(7-8):226-31. PubMed ID: 1181591
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tablets. XIV. Influence of Precirol on the in vitro liberation of sodium salicylate. The process of granulation and inclusion].
    Terrier JL; Touré P; Meimoun J; Duchène D; Puisieux F
    Pharm Acta Helv; 1975; 50(7-8):219-25. PubMed ID: 1181590
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L; Naplatanova D
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Ukich AW; Goatcher PM
    Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of technology and formulation for the mechanisms of continuous liberation of potassium chloride from hydrophilic matrices. 2. Effect of compression force, particle size and density of the tablet].
    Salomon JL; Vuagnat P; Doelker E; Buri P
    Pharm Acta Helv; 1979; 54(3):86-9. PubMed ID: 482302
    [No Abstract]   [Full Text] [Related]  

  • 7. [Formulation of sustained-release tablets. II. Hydrophilic matrices].
    Buri P; Doelker E
    Pharm Acta Helv; 1980; 55(7-8):189-97. PubMed ID: 7433467
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advances in the production and control of tablets. XVI. Various types of oral preparations with delayed action].
    Chalabala M; Vitková M
    Cesk Farm; 1976 Mar; 25(2):79-81. PubMed ID: 1277318
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
    Cui Q; Zhu Y; Cui J
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: A solid dosage form with constant release.
    Lerk CF; Bolink WJ; Zuurman K
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:151P. PubMed ID: 4150556
    [No Abstract]   [Full Text] [Related]  

  • 11. [Injection-molding technic for the production of oral delayed-action preparations. 3. Addition of highly water-soluble substances].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1975 Aug; 30(8):536-40. PubMed ID: 1178778
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preparation of delayed action micropills of oxytetracycline and their in vitro study].
    Pandula E; Tarjányi S; Csontos A; Nagy I
    Acta Pharm Hung; 1968 Nov; 38(6):400-4. PubMed ID: 5706380
    [No Abstract]   [Full Text] [Related]  

  • 13. The prolonged release of caramiphen hydrochloride and atropine sulfate from compressed tablets containing carbopol 934.
    Baun DC; Walker GC
    Pharm Acta Helv; 1971 Feb; 46(2):94-113. PubMed ID: 5142666
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma salicylate concentrations following chronic administration of aspirin as conventional and sustained-release tablets.
    Wiseman EH
    Curr Ther Res Clin Exp; 1969 Nov; 11(11):681-9. PubMed ID: 4982303
    [No Abstract]   [Full Text] [Related]  

  • 16. [Injection die-casting procedure in the preparation of oral delayed-action preparations. 7. Curing with energy-rich radiation].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1977 Jan; 32(1):30-3. PubMed ID: 840875
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
    Ozeki Y; Ando M; Watanabe Y; Danjo K
    J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
    Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
    Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the manufacture and testing of butaperazine matrix tablets with silicone varnish NH 30 as a structural substance (author's transl)].
    Kala H; Wendorff D; Moldenhauer H
    Pharmazie; 1980; 35(7):418-23. PubMed ID: 6106210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Formulation of sustained release tablets. I. Inert matrices].
    Salomen JL; Doelker E
    Pharm Acta Helv; 1980; 55(7):174-82. PubMed ID: 7413682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.